blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3604316

EP3604316 - SYNTHESIS OF BORONATE SALTS [Right-click to bookmark this link]
StatusThe patent has been granted
Status updated on  03.11.2023
Database last updated on 03.09.2024
FormerGrant of patent is intended
Status updated on  13.06.2023
FormerExamination is in progress
Status updated on  19.05.2023
FormerGrant of patent is intended
Status updated on  09.01.2023
FormerExamination is in progress
Status updated on  18.02.2022
FormerRequest for examination was made
Status updated on  07.08.2020
FormerThe application has been published
Status updated on  03.01.2020
Most recent event   Tooltip02.08.2024Lapse of the patent in a contracting state
New state(s): PT, SK
published on 04.09.2024 [2024/36]
Applicant(s)For all designated states
Melinta Therapeutics, Inc.
389 Interpace Parkway, Suite 450
Parsippany, NJ 07054 / US
[2023/45]
Former [2021/23]For all designated states
Melinta Therapeutics, Inc.
44 Whippany Road
Suite 280
Morristown, NJ 07960 / US
Former [2020/06]For all designated states
Rempex Pharmaceuticals, Inc.
300 TriState International, Suite 272
Lincolnshire, IL / US
Inventor(s)01 / HECKER, Scott
4802 Rancho Viejo Dr.
Del Mar, CA 92014 / US
02 / BOYER, Serge
5112 Castle Hills Drive
San Diego, CA 92109 / US
 [2020/06]
Representative(s)Heller, Benjamin Henry, et al
Kilburn & Strode LLP
Lacon London
84 Theobalds Road
London WC1X 8NL / GB
[2020/06]
Application number, filing date19186092.330.04.2015
[2020/06]
Priority number, dateUS201461988690P05.05.2014         Original published format: US 201461988690 P
[2020/06]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3604316
Date:05.02.2020
Language:EN
[2020/06]
Type: B1 Patent specification 
No.:EP3604316
Date:06.12.2023
Language:EN
[2023/49]
Search report(s)(Supplementary) European search report - dispatched on:EP27.09.2019
ClassificationIPC:C07F5/04, C07F5/02, A01N55/08
[2020/06]
CPC:
C07F5/025 (EP,US); A01N55/08 (EP,US)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2020/37]
Former [2020/06]AL,  AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  RS,  SE,  SI,  SK,  SM,  TR 
TitleGerman:SYNTHESE VON BORONATSALZEN[2020/06]
English:SYNTHESIS OF BORONATE SALTS[2020/06]
French:SYNTHÈSE DE SELS DE BORONATE[2020/06]
Examination procedure05.08.2020Amendment by applicant (claims and/or description)
05.08.2020Examination requested  [2020/37]
05.08.2020Date on which the examining division has become responsible
21.02.2022Despatch of a communication from the examining division (Time limit: M04)
01.07.2022Reply to a communication from the examining division
10.01.2023Communication of intention to grant the patent
16.05.2023Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
14.06.2023Communication of intention to grant the patent
24.10.2023Fee for grant paid
24.10.2023Fee for publishing/printing paid
24.10.2023Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP15788682.1  / EP3140310
Divisional application(s)EP23214076.4  / EP4356736
Fees paidRenewal fee
11.11.2019Renewal fee patent year 03
11.11.2019Renewal fee patent year 04
11.11.2019Renewal fee patent year 05
27.04.2020Renewal fee patent year 06
27.04.2021Renewal fee patent year 07
27.04.2022Renewal fee patent year 08
27.04.2023Renewal fee patent year 09
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipCZ06.12.2023
EE06.12.2023
HR06.12.2023
LV06.12.2023
NL06.12.2023
RO06.12.2023
RS06.12.2023
SE06.12.2023
SK06.12.2023
SM06.12.2023
BG06.03.2024
NO06.03.2024
IS06.04.2024
PT08.04.2024
[2024/36]
Former [2024/35]CZ06.12.2023
EE06.12.2023
HR06.12.2023
LV06.12.2023
NL06.12.2023
RO06.12.2023
RS06.12.2023
SE06.12.2023
SM06.12.2023
BG06.03.2024
NO06.03.2024
IS06.04.2024
Former [2024/34]EE06.12.2023
HR06.12.2023
LV06.12.2023
NL06.12.2023
RS06.12.2023
SE06.12.2023
SM06.12.2023
BG06.03.2024
NO06.03.2024
IS06.04.2024
Former [2024/33]HR06.12.2023
LV06.12.2023
NL06.12.2023
RS06.12.2023
SE06.12.2023
SM06.12.2023
BG06.03.2024
NO06.03.2024
IS06.04.2024
Former [2024/32]HR06.12.2023
LV06.12.2023
NL06.12.2023
RS06.12.2023
SE06.12.2023
BG06.03.2024
NO06.03.2024
IS06.04.2024
Former [2024/26]HR06.12.2023
LV06.12.2023
NL06.12.2023
RS06.12.2023
SE06.12.2023
BG06.03.2024
NO06.03.2024
Former [2024/25]HR06.12.2023
RS06.12.2023
SE06.12.2023
BG06.03.2024
NO06.03.2024
Former [2024/21]BG06.03.2024
Documents cited:Search[A]WO2012021455  (REMPEX PHARMACEUTICALS INC [US], et al)
by applicantWO8705297
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.